Manulife (Manufacturers Life Insurance)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,450
| Closed | -$305K | – | 3075 |
|
|
2024
Q2 | $305K | Sell |
7,450
-24,608
| -77% | -$1.01M | ﹤0.01% | 2415 |
|
|
2024
Q1 | $1.36M | Sell |
32,058
-4,776
| -13% | -$202K | ﹤0.01% | 1683 |
|
|
2023
Q4 | $1.56M | Sell |
36,834
-122,137
| -77% | -$5.18M | ﹤0.01% | 1566 |
|
|
2023
Q3 | $3.47M | Buy |
158,971
+12,875
| +9% | +$281K | ﹤0.01% | 1266 |
|
|
2023
Q2 | $4.64M | Buy |
146,096
+18,685
| +15% | +$594K | ﹤0.01% | 1121 |
|
|
2023
Q1 | $3.11M | Buy |
127,411
+5,572
| +5% | +$136K | ﹤0.01% | 1259 |
|
|
2022
Q4 | $3.85M | Buy |
121,839
+3,673
| +3% | +$116K | ﹤0.01% | 1180 |
|
|
2022
Q3 | $3.3M | Buy |
118,166
+3,843
| +3% | +$107K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $3.07M | Buy |
114,323
+4,938
| +5% | +$133K | ﹤0.01% | 1318 |
|
|
2022
Q1 | $3.7M | Buy |
109,385
+89,596
| +453% | +$3.03M | ﹤0.01% | 1328 |
|
|
2021
Q4 | $650 | Sell |
19,789
-265
| -1% | -$9 | ﹤0.01% | 2093 |
|
|
2021
Q3 | $592K | Sell |
20,054
-123
| -0.6% | -$3.63K | ﹤0.01% | 2165 |
|
|
2021
Q2 | $517K | Buy |
+20,177
| New | +$517K | ﹤0.01% | 2403 |
|